Return to Trial Database

HCRN-GU19-385

Phase II Trial of Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer (PLANE-PC)

Status

Enrollment Closed

Cancer Type(s)

Study Contact

studies@hoosiercancer.org

Trial Locations

All sites in which the trial HCRN-GU19-385 being conducted in.

Froedtert & the Medical College of Wisconsin

Knight Cancer Institute at Oregon Health & Science University

University of Michigan Rogel Cancer Center

Winship Cancer Institute of Emory University